Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe Log In

Needed: New models for ‘pandemic-lens investing’

ImpactAlpha, Feb. 26SARS. Zika. Ebola. The coronavirus is the latest infectious outbreak wreaking social and economic havoc.

The World Health Organization has warned that dangerous pathogens may become more common in the face of climate change, urbanization and overuse of antibiotics. On Tuesday, the Centers for Disease Control warned Americans that things “could get bad,” and the Trump administration asked for $1 billion to counter the coronavirus (even as he has proposed budget cuts for critical health agencies).

The U.S. isn’t the only country unprepared for a pandemic. Action on the climate crisis is measured in years or even decades; containing a pandemic requires both immediate action and long-term preparedness. Vaccines, for example, take many years and billions of dollars to bring to market.

Some ways to bridge the gap:  

Pandemic bonds. Amid the 2016 Ebola outbreak, the World Bank created the Pandemic Emergency Financing Facility, a “catastrophe bond” aimed at getting “surge funding” to developing countries at risk. The World Bank’s Jim Yong Kim promised the bond would create “an entirely new market for pandemic risk insurance.”

The offering raised $320 million from bond investors, pension funds and asset managers in the U.S. and Europe. The high yields were offset by the risk of losing principal in the event of a pandemic. Now we have one, but no payout has been triggered. That will happen only 12 weeks after the start of an outbreak and after at least 20 deaths in two countries. That costs valuable time, critics say.

“The whole scheme is set up to minimize the probability of payout,” Harvard Global Health Institute’s Olga Jonas told The Wall Street Journal

Catalyzing R&D funding. The Coalition for Epidemic Preparedness (CEPI) was founded in 2017 by the governments of Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum. Some of the $760 million it has raised has been channeled to biotech companies developing critical vaccines.

One CEPI fundee, Cambridge, Mass.-based biotech firm Moderna, shipped its first batch of a Coronavirus vaccine for testing this week. A clinical trial could begin by May. 

Innovation ecosystem. Austin-based PandemicTech, a “virtual incubator” and resource network, takes a more localized approach to fighting pandemic infectious disease threats. This year, $100,000 in awards to PandemicTech Fellows will give special consideration to projects that address the coronavirus. 

Tech solutions. Vaccines and pandemics have been the realm of governments and philanthropy. But the global health challenge opens up opportunities for impact investors as well. focused on fighting pandemic infectious disease threats,

Two potential areas: better diagnostic tools for distributed testing, and technology that can accelerate clinical trials, says Skoll Foundation’s Bruce Lowry.

You might also like...